HR 1720
117th Congress
House
Health
Appropriations
Cardiovascular and respiratory health
Emergency medical services and trauma care
Health technology, devices, supplies
Immunology and vaccination
Infectious and parasitic diseases
Manufacturing
Medical tests and diagnostic methods
Military procurement, research, weapons development
Public contracts and procurement
Worker safety and health
COVID–19 Medical Production Act
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Mar 9, 2021
Referred to the House Committee on Financial Services.
Mar 9, 2021
Introduced in House
Plain-English summary
COVID-19 Medical Production Act
This bill provides additional funding for FY2021 to acquire medical supplies, vaccines, and other equipment to combat COVID-19 (i.e., coronavirus disease 2019) using authorities under the Defense Production Act of 1950. That act confers on the President a broad set of authorities to influence domestic industry to provide essential materials and goods for the national defense.
This funding is available through FY2025. Beginning in FY2023, it may be used to meet public health needs to address any pathogen determined by the President to have the potential to create a public health emergency.
What's happening now
Referred to the House Committee on Financial Services.
Committees of jurisdiction
1
Cosponsors
1